Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Embryo drop-out rates in preimplantation genetic testing for aneuploidy (PGT-A): a retrospective data analysis from the DoLoRes study

B. Wirleitner, M. Hrubá, M. Schuff, L. Hradecký, A. Stecher, A. Damko, J. Stadler, D. Spitzer, M. Obkircher, M. Murtinger

. 2024 ; 41 (1) : 193-203. [pub] 20231025

Language English Country Netherlands

Document type Multicenter Study, Journal Article

E-resources Online Full text

NLK Free Medical Journals from 2008 to 1 year ago
PubMed Central from 1997 to 1 year ago
Europe PubMed Central from 1997 to 1 year ago
ProQuest Central from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2011-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1999-01-01 to 1 year ago
Public Health Database (ProQuest) from 1999-01-01 to 1 year ago

PURPOSE: To evaluate the decline in transferable embryos in preimplantation genetic testing for aneuploidy (PGT-A) cycles due to (a) non-biopsable blastocyst quality, (b) failure of genetic analysis, (c) diagnosis of uniform numerical or structural chromosomal aberrations, and/or (d) chromosomal aberrations in mosaic constitution. METHODS: This retrospective multicenter study comprised outcomes of 1562 blastocysts originating from 363 controlled ovarian stimulation cycles, respectively, 226 IVF couples in the period between January 2016 and December 2018. Inclusion criteria were PGT-A cycles with trophectoderm biopsy (TB) and next generation sequencing (NGS). RESULTS: Out of 1562 blastocysts, 25.8% were lost due to non-biopsable and/or non-freezable embryo quality. In 10.3% of all biopsied blastocysts, genetic analysis failed. After exclusion of embryos with uniform or chromosomal aberrations in mosaic, only 18.1% of those originally yielded remained as diagnosed euploid embryos suitable for transfer. This translates into 50.4% of patients and 57.6% of stimulated cycles with no euploid embryo left for transfer. The risk that no transfer can take place rose significantly with a lower number of oocytes and with increasing maternal age. The chance for at least one euploid blastocyst/cycle in advanced maternal age (AMA)-patients was 33.3% compared to 52.1% in recurrent miscarriage (RM), 59.8% in recurrent implantation failure (RIF), and 60.0% in severe male factor (SMF). CONCLUSIONS: The present study demonstrates that PGT-A is accompanied by high embryo drop-out rates. IVF-practitioners should be aware that their patients run a high risk of ending up without any embryo suitable for transfer after (several) stimulation cycles, especially in AMA patients. Patients should be informed in detail about the frequency of inconclusive or mosaic results, with the associated risk of not having an euploid embryo available for transfer after PGT-A, as well as the high cost involved in this type of testing.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007817
003      
CZ-PrNML
005      
20240423160308.0
007      
ta
008      
240412s2024 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10815-023-02976-9 $2 doi
035    __
$a (PubMed)37878220
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Wirleitner, Barbara $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria. Barbara.wirleitner@ivf.at $1 https://orcid.org/0009000389762561
245    10
$a Embryo drop-out rates in preimplantation genetic testing for aneuploidy (PGT-A): a retrospective data analysis from the DoLoRes study / $c B. Wirleitner, M. Hrubá, M. Schuff, L. Hradecký, A. Stecher, A. Damko, J. Stadler, D. Spitzer, M. Obkircher, M. Murtinger
520    9_
$a PURPOSE: To evaluate the decline in transferable embryos in preimplantation genetic testing for aneuploidy (PGT-A) cycles due to (a) non-biopsable blastocyst quality, (b) failure of genetic analysis, (c) diagnosis of uniform numerical or structural chromosomal aberrations, and/or (d) chromosomal aberrations in mosaic constitution. METHODS: This retrospective multicenter study comprised outcomes of 1562 blastocysts originating from 363 controlled ovarian stimulation cycles, respectively, 226 IVF couples in the period between January 2016 and December 2018. Inclusion criteria were PGT-A cycles with trophectoderm biopsy (TB) and next generation sequencing (NGS). RESULTS: Out of 1562 blastocysts, 25.8% were lost due to non-biopsable and/or non-freezable embryo quality. In 10.3% of all biopsied blastocysts, genetic analysis failed. After exclusion of embryos with uniform or chromosomal aberrations in mosaic, only 18.1% of those originally yielded remained as diagnosed euploid embryos suitable for transfer. This translates into 50.4% of patients and 57.6% of stimulated cycles with no euploid embryo left for transfer. The risk that no transfer can take place rose significantly with a lower number of oocytes and with increasing maternal age. The chance for at least one euploid blastocyst/cycle in advanced maternal age (AMA)-patients was 33.3% compared to 52.1% in recurrent miscarriage (RM), 59.8% in recurrent implantation failure (RIF), and 60.0% in severe male factor (SMF). CONCLUSIONS: The present study demonstrates that PGT-A is accompanied by high embryo drop-out rates. IVF-practitioners should be aware that their patients run a high risk of ending up without any embryo suitable for transfer after (several) stimulation cycles, especially in AMA patients. Patients should be informed in detail about the frequency of inconclusive or mosaic results, with the associated risk of not having an euploid embryo available for transfer after PGT-A, as well as the high cost involved in this type of testing.
650    _2
$a těhotenství $7 D011247
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a preimplantační diagnóza $x metody $7 D019836
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a genetické testování $x metody $7 D005820
650    _2
$a blastocysta $x patologie $7 D001755
650    _2
$a aneuploidie $7 D000782
655    _2
$a multicentrická studie $7 D016448
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hrubá, Martina $u Next Fertility IVF Prof. Zech, Smetany 2, 30100, Pilsen, Czech Republic $u Next Lab Genetika, Parková 11a, 32600, Pilsen, Czech Republic
700    1_
$a Schuff, Maximilian $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria
700    1_
$a Hradecký, Libor $u Next Fertility IVF Prof. Zech, Smetany 2, 30100, Pilsen, Czech Republic
700    1_
$a Stecher, Astrid $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria
700    1_
$a Damko, Adriane $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria
700    1_
$a Stadler, Jürgen $u Next Fertility IVF Prof. Zech, Innsbrucker Bundesstrasse 35, 5020, Salzburg, Austria
700    1_
$a Spitzer, Dietmar $u Next Fertility IVF Prof. Zech, Innsbrucker Bundesstrasse 35, 5020, Salzburg, Austria
700    1_
$a Obkircher, Marlene $u Next Fertility Eubios, Fossato Molini 9, 39012, Merano, Italy
700    1_
$a Murtinger, Maximilian $u Next Fertility IVF Prof. Zech, Roemerstrasse 2, 6900, Bregenz, Austria $u Next Fertility St. Gallen, Kürsteinerstrasse 2, 9015, St. Gallen, Switzerland
773    0_
$w MED00002533 $t Journal of assisted reproduction and genetics $x 1573-7330 $g Roč. 41, č. 1 (2024), s. 193-203
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37878220 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160304 $b ABA008
999    __
$a ok $b bmc $g 2081673 $s 1217584
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 41 $c 1 $d 193-203 $e 20231025 $i 1573-7330 $m Journal of assisted reproduction and genetics $n J Assist Reprod Genet $x MED00002533
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...